Table 1.
Baseline characteristics of patients in the outcome cohort
| Characteristic | n=220 |
|---|---|
| Recipient age, yr | 13 (5–16) |
| Recipient sex | |
| Boys | 117 (53) |
| Living donor kidney transplantation | 54 (25) |
| HLA match | |
| 0–1 | 120 (55) |
| 2–4 | 97 (44) |
| 5–6 | 3 (1) |
| Peak PRA, % | |
| <10 | 121 (55) |
| 10–49 | 65 (30) |
| 50–100 | 34 (15) |
| Follow-up time, mo | 44 (26–66) |
| No. of tacrolimus trough levels per patient | 59 (38–87) |
| Median tacrolimus trough level,a ng/ml | 5.8 (4.4–7.5) |
| Median tacrolimus IPV,a % | 31 (22–42) |
Data are presented as median (interquartile range) for continuous variables and as number (percentage) for categorical variables. Peak PRA indicates historic peak PRA. PRA, panel reactive antibody; No., number; IPV, intrapatient variability.
a
Tacrolimus levels before 10 months post-transplant were excluded from these analyses.